Exploring Anticancer Properties of Medicinal Plants against Breast Cancer by Downregulating Human Epidermal Growth Factor Receptor 2-Reference-Cited by-同舟云学术

Exploring Anticancer Properties of Medicinal Plants against Breast Cancer by Downregulating Human Epidermal Growth Factor Receptor 2

Published:2024-04-16 Issue:17 Volume:72 Page:9717-9734
ISSN:0021-8561
Container-title:Journal of Agricultural and Food Chemistry
language:en
Short-container-title:J. Agric. Food Chem.

Author:

Gupta Sunny¹,Prem Rashima²,Sethy Chinmayee¹,Shrivastava Saurabh¹,Singh Manju³,Yadav Pramod⁴,Huddar VG⁴,Prajapati PK⁴,Roy Anita¹,Sundd Monica²^ORCID,Patel Ashok Kumar¹^ORCID

Affiliation:

1. Kusuma School of Biological Sciences, Indian Institute of Technology Delhi, New Delhi 110016, India

2. National Institute of Immunology, New Delhi 110067, India

3. CSIR Institute of Genomics and Integrative Biology, New Delhi 110025, India

4. All India Institute of Ayurveda Delhi, New Delhi 110076, India

Funder

Indian Institute of Technology Delhi

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jafc.3c07565

Reference95 articles.

1. Molecular Classification of Breast Carcinoma: From Traditional, Old-Fashioned Way to A New Age, and A New Way

2. Histological and molecular classification of breast cancer: what do we know?

3. Vogel, C.; Cobleigh, M. A.; Tripathy, D.; Gutheil, J. C.; Harris, L. N.; Fehrenbacher, L.; Slamon, D. J.; Murphy, M.; Novotny, W. F.; Burchmore, M.; Shak, S.; Stewart, S. J. First-Line, Single-Agent Herceptin 1 (Trastuzumab) in Metastatic Breast Cancer: A Preliminary Report on Behalf of the Genentech H0650 Study Investigators. www.ejconline.com.

4. The mechanistic insights of the arrhythmogenic effect of trastuzumab

5. CMTM6 overexpression confers trastuzumab resistance in HER2-positive breast cancer